FDA.reportPublic FDA data

Application 200174

Type
ANDA
Sponsor
PERRIGO UK FINCO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATEBETAMETHASONE DIPROPIONATE; CALCIPOTRIENEOINTMENT;TOPICAL0.064%;0.005%NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
45802-816Calcipotriene and Betamethasone DipropionateCalcipotriene, Betamethasone DipropionatePadagis Israel Pharmaceuticals LtdANDACurrent
45802-816Calcipotriene and Betamethasone DipropionateCalcipotriene, Betamethasone DipropionatePerrigo New York IncANDACurrent
63629-2520Calcipotriene and Betamethasone DipropionateCalcipotriene, Betamethasone DipropionateBryant Ranch PrepackANDACurrent
63629-2520Calcipotriene and Betamethasone DipropionateCalcipotriene, Betamethasone DipropionateBryant Ranch PrepackANDACurrent
63629-2520Calcipotriene and Betamethasone DipropionateCalcipotriene, Betamethasone DipropionateBryant Ranch PrepackANDACurrent
63629-8617Calcipotriene and Betamethasone DipropionateCalcipotriene, Betamethasone DipropionateBryant Ranch PrepackANDACurrent
63629-8617Calcipotriene and Betamethasone DipropionateCalcipotriene, Betamethasone DipropionateBryant Ranch PrepackANDACurrent
63629-8617Calcipotriene and Betamethasone DipropionateCalcipotriene, Betamethasone DipropionateBryant Ranch PrepackANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
9797ORIG2014-12-17